Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood loss

Oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood loss

US Patent 11351132 · Granted Jun 7, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multiphasic contraceptive regimen for oral combination drug formulation of proge2025
Treatment of endometriosis by intravaginal administration of a low dose of a sel2024
Oral combination drug formulation comprising a non-steroidal anti-inflammatory d2023
Multiphasic contraceptive regimen for oral combination drug formulation of proge2023
Treatment of endometriosis by intravaginal administration of a low dose of a sel2021
Multiphasic contraceptive regimen for oral combination drug formulation of proge2021
Oral combination drug formulation comprising a non-steroidal anti-inflammatory d2020
Multiphasic contraceptive regimen for oral combination drug formulation of proge2020
Oral combination drug formulation comprising a non-steroidal anti-inflammatory d2020
Multiphasic contraceptive regimen for oral combination drug formulation of proge2019
Treatment of endometriosis by intravaginal administration of a low dose of a sel2019
Multiphasic contraceptive regimen for oral combination drug formulation of proge2018